The roles of ras family small GTPases in breast cancer

Ariella B. Hanker, Channing J. Der

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Members of the Ras subfamily of small GTPases may represent attractive targets for the treatment of breast cancer, but more research is needed to fully understand the roles these proteins play in breast cancer. Other small GTPases, including members of the Rho and Rab subfamilies, which are implicated in breast cancer, are reviewed. This chapter focuses on these Ras family proteins involved in breast cancer and on possible strategies to correct the cancer related defects in these proteins for breast cancer treatment. Currently, GTPases are not considered promising druggable targets. Since GTPases bind GTP with nanomolar to picomolar affinities, small molecule approaches to block GTP binding are not feasible. Recent work has revealed a mechanism by which H-Ras expression is elevated in breast tumor initiating cells, which may represent breast cancer "stem cells." There are several other members of the Ras subfamily that have been implicated in breast cancer, but more studies are needed to determine the importance of these proteins in breast cancer. As strategies to therapeutically inhibit small GTPase signaling improve, it will be imperative to understand the contributions of each of these proteins to breast cancer development and progression.

Original languageEnglish (US)
Title of host publicationHandbook of Cell Signaling, 2/e
PublisherElsevier Inc.
Pages2763-2772
Number of pages10
Volume3
ISBN (Print)9780123741455
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Monomeric GTP-Binding Proteins
Breast Neoplasms
GTP Phosphohydrolases
Guanosine Triphosphate
Proteins
Oncology
Neoplastic Stem Cells
Stem cells
Tumors
ras Proteins
Defects
Molecules

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hanker, A. B., & Der, C. J. (2010). The roles of ras family small GTPases in breast cancer. In Handbook of Cell Signaling, 2/e (Vol. 3, pp. 2763-2772). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374145-5.00322-3

The roles of ras family small GTPases in breast cancer. / Hanker, Ariella B.; Der, Channing J.

Handbook of Cell Signaling, 2/e. Vol. 3 Elsevier Inc., 2010. p. 2763-2772.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hanker, AB & Der, CJ 2010, The roles of ras family small GTPases in breast cancer. in Handbook of Cell Signaling, 2/e. vol. 3, Elsevier Inc., pp. 2763-2772. https://doi.org/10.1016/B978-0-12-374145-5.00322-3
Hanker AB, Der CJ. The roles of ras family small GTPases in breast cancer. In Handbook of Cell Signaling, 2/e. Vol. 3. Elsevier Inc. 2010. p. 2763-2772 https://doi.org/10.1016/B978-0-12-374145-5.00322-3
Hanker, Ariella B. ; Der, Channing J. / The roles of ras family small GTPases in breast cancer. Handbook of Cell Signaling, 2/e. Vol. 3 Elsevier Inc., 2010. pp. 2763-2772
@inbook{cfd9186a4c5c468e80270df61c86a647,
title = "The roles of ras family small GTPases in breast cancer",
abstract = "Members of the Ras subfamily of small GTPases may represent attractive targets for the treatment of breast cancer, but more research is needed to fully understand the roles these proteins play in breast cancer. Other small GTPases, including members of the Rho and Rab subfamilies, which are implicated in breast cancer, are reviewed. This chapter focuses on these Ras family proteins involved in breast cancer and on possible strategies to correct the cancer related defects in these proteins for breast cancer treatment. Currently, GTPases are not considered promising druggable targets. Since GTPases bind GTP with nanomolar to picomolar affinities, small molecule approaches to block GTP binding are not feasible. Recent work has revealed a mechanism by which H-Ras expression is elevated in breast tumor initiating cells, which may represent breast cancer {"}stem cells.{"} There are several other members of the Ras subfamily that have been implicated in breast cancer, but more studies are needed to determine the importance of these proteins in breast cancer. As strategies to therapeutically inhibit small GTPase signaling improve, it will be imperative to understand the contributions of each of these proteins to breast cancer development and progression.",
author = "Hanker, {Ariella B.} and Der, {Channing J.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-374145-5.00322-3",
language = "English (US)",
isbn = "9780123741455",
volume = "3",
pages = "2763--2772",
booktitle = "Handbook of Cell Signaling, 2/e",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The roles of ras family small GTPases in breast cancer

AU - Hanker, Ariella B.

AU - Der, Channing J.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Members of the Ras subfamily of small GTPases may represent attractive targets for the treatment of breast cancer, but more research is needed to fully understand the roles these proteins play in breast cancer. Other small GTPases, including members of the Rho and Rab subfamilies, which are implicated in breast cancer, are reviewed. This chapter focuses on these Ras family proteins involved in breast cancer and on possible strategies to correct the cancer related defects in these proteins for breast cancer treatment. Currently, GTPases are not considered promising druggable targets. Since GTPases bind GTP with nanomolar to picomolar affinities, small molecule approaches to block GTP binding are not feasible. Recent work has revealed a mechanism by which H-Ras expression is elevated in breast tumor initiating cells, which may represent breast cancer "stem cells." There are several other members of the Ras subfamily that have been implicated in breast cancer, but more studies are needed to determine the importance of these proteins in breast cancer. As strategies to therapeutically inhibit small GTPase signaling improve, it will be imperative to understand the contributions of each of these proteins to breast cancer development and progression.

AB - Members of the Ras subfamily of small GTPases may represent attractive targets for the treatment of breast cancer, but more research is needed to fully understand the roles these proteins play in breast cancer. Other small GTPases, including members of the Rho and Rab subfamilies, which are implicated in breast cancer, are reviewed. This chapter focuses on these Ras family proteins involved in breast cancer and on possible strategies to correct the cancer related defects in these proteins for breast cancer treatment. Currently, GTPases are not considered promising druggable targets. Since GTPases bind GTP with nanomolar to picomolar affinities, small molecule approaches to block GTP binding are not feasible. Recent work has revealed a mechanism by which H-Ras expression is elevated in breast tumor initiating cells, which may represent breast cancer "stem cells." There are several other members of the Ras subfamily that have been implicated in breast cancer, but more studies are needed to determine the importance of these proteins in breast cancer. As strategies to therapeutically inhibit small GTPase signaling improve, it will be imperative to understand the contributions of each of these proteins to breast cancer development and progression.

UR - http://www.scopus.com/inward/record.url?scp=79952047902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952047902&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374145-5.00322-3

DO - 10.1016/B978-0-12-374145-5.00322-3

M3 - Chapter

AN - SCOPUS:79952047902

SN - 9780123741455

VL - 3

SP - 2763

EP - 2772

BT - Handbook of Cell Signaling, 2/e

PB - Elsevier Inc.

ER -